Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics.

In addition, across the non-cBR subgroups, although patients with PR demonstrated better prognosis compared to those with SD/PD, the differences did not reach statistical significance for DFS ( P > 0.05; Fig. 3 B), suggesting that patients who did not successfully achieve biological response (non-cBR) would have equally inferior long-term tumor control regardless of radiological PR or SD/PD.

also in 111,027 other papers